Public Board of Directors papers 260123

Public meeting of the Board of Directors Thursday 2 4 th Novem ber at 12.45 pm Trust Admin meeting room 6 & by virtual means

Present: Chair: Chris Outram (CO), Chairman

Roger Spencer (RS), Chief Executive Officer Kathryn Riddle (KR), Non-Executive Director Dr Jane Maher (JM), Non-Executive Director Robert Ainsworth (RA), Non-Executive Director Alveena Malik (AM), Non-Executive Director

Tarun Kapur (TK), Non-Executive Director Grenville Page (GP), Non-Executive Director Prof Chris Harrison (CJH), Deputy CEO Bernie Delahoyde (BD), Chief Operating Officer Eve Lightfoot (EL), Director of Workforce Prof Janelle Yorke (JY), Executive Chief Nurse & Director of Quality Dr Neil Bayman (NB), Executive Medical Director Sally Parkinson (SP), Interim Executive Director of Finance

Prof Richard Fuller (RF), Director of Education Prof Fiona Blackhall (FB), Director of Research John Wareing, Director of Strategy

Minutes: Louise Westcott, Company Secretary In attendance: Jo D’Arcy, Assistant Company Secretary

Anne Cairns, Regional Access Manager- Janssen Clinical presentation Public Involvement Process to Enhance Diversity in Technology Clinical Trials, Donna Graham, Consultant & Leanna Goodwin, Research Practitioner LG Introduced herself as part of the Digital Experimental Cancer Medicine Team (ECMT) There are a number of groups who are underserved by clinical research. In the UK there are no legal requirements to represent the underserved populations in research trials. The patient, practical, community and research barriers were outlined. Training, communication and other ways of improving inclusivity were outlined. LG described the process of finding out the barriers to research covering things like bringing research closer to home, flexibility of study design, training of research staff and digital technology to enable remote access. The Digital ECMT conducts technology clinical trials. This covers medical devices, software and AI, study designs are the same as with drug trials. They were looking to change the role of the patient and to bring clinical benefits to all patients. A key aspect of the ECMT strategy is to make the patient a co-worker in trials. The team are looking to include all patients in this. They partnered with a company called VOCAL. Workshops were put in place. Mapping of the technology for the clinical trials process identified ways to improve inclusivity. Looked at developing improvements in the design, development and delivery of the trials by breaking down each element and getting feedback. The insights gained from this project led to the development of principles to govern future trials. 5 stages were identified around taking action to identify inequalities, being informed by data, involving people from diverse backgrounds, removing barriers and documenting & sharing learning. An interactive checklist was developed for use in future Technology Clinical Trials.

2